CVS Health (CVS) earnings Q1 2026

CVS Health (CVS) earnings Q1 2026

A display screen shows the emblem and buying and selling data for CVS on the New York Stock Exchange, March 24, 2026. Jeenah Moon | Reuters CVS Health on Wednesday blew previous first-quarter earnings and income estimates and raised its 2026 steering, as its once-troubled insurance coverage enterprise confirmed enchancment. CVS, which operates the nation’s…

Read Full News
Pfizer (PFE) earnings Q1 2026

Pfizer (PFE) earnings Q1 2026

Exterior view of the Pfizer headquarters constructing on January 29, 2023 in New York City. View Press | Corbis News | Getty Images Pfizer on Tuesday posted first-quarter earnings and income that topped estimates and reaffirmed its 2026 outlook, as lately launched and purchased merchandise present development. Here’s what the corporate reported for the primary…

Read Full News
Vanda Pharmaceuticals Announces US Commercial Availability of NEREUS (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years

Vanda Pharmaceuticals Announces US Commercial Availability of NEREUS (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years

Consumers can now order NEREUS instantly at nereus.us WASHINGTON, May 1, 2026 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) at present introduced that NEREUS (tradipitant) is now commercially obtainable throughout the United States for the prevention of vomiting induced by movement in adults, marking the first new prescription drugs authorised for this situation in…

Read Full News
Eli Lilly (LLY) earnings Q1 2026

Eli Lilly (LLY) earnings Q1 2026

David Ricks, chief government officer of Eli Lilly & Co., on the Semafor World Economy Summit in the course of the International Monetary Fund (IMF) and World Bank Spring conferences in Washington, DC, US, on Friday, April 17, 2026. Aaron Schwartz | Bloomberg | Getty Images Eli Lilly on Thursday reported first-quarter earnings and income…

Read Full News
Crispr gene editing treatment from Intellia succeeds in Phase 3 trial

Crispr gene editing treatment from Intellia succeeds in Phase 3 trial

Intellia Therapeutics, constructing exterior and firm signal, Cambridge, Massachusetts, USA. Spencer Grant | Universal Images Group | Getty Images Intellia Therapeutics stated its Crispr-based treatment for a uncommon swelling situation met its objectives in a late-stage trial, marking a milestone for the sector of gene editing and placing the corporate on monitor to hunt approval…

Read Full News
UnitedHealth Group (UNH) earnings Q1 2026

UnitedHealth Group (UNH) earnings Q1 2026

UnitedHealthcare signal is displayed at its workplace constructing in Minnetonka, Minnesota, US, Dec. 11, 2025. Tim Evans | Reuters UnitedHealth Group on Tuesday posted first-quarter earnings that topped estimates and raised its 2026 revenue outlook, as the corporate higher manages excessive medical prices and streamlines its operations. The nation’s largest personal insurer mentioned it expects…

Read Full News